These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6142671

  • 61. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
    van Hees PA.
    Acta Gastroenterol Belg; 1987; 50(5):555-9. PubMed ID: 2902723
    [No Abstract] [Full Text] [Related]

  • 62. Sulphasalazine and spermatogenesis.
    Freeman JG, Reece VA, Venables CW.
    Digestion; 1982; 23(1):68-71. PubMed ID: 6123457
    [Abstract] [Full Text] [Related]

  • 63. [Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
    Dölle W, Daiss W.
    Verh Dtsch Ges Inn Med; 1988; 94():184-91. PubMed ID: 2905099
    [No Abstract] [Full Text] [Related]

  • 64. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.
    Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW.
    Gastroenterology; 1981 Jan; 80(1):72-6. PubMed ID: 6108894
    [Abstract] [Full Text] [Related]

  • 65. Bullous pemphigoid following use of sulphasalazine for ulcerative colitis: drug-induced eruption or true association?
    Vaccaro M, D'Amico D, Borgia F, Guarneri F, Cannavò S.
    Dermatology; 2001 Jan; 203(2):194-5. PubMed ID: 11586028
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT.
    N Z Med J; 1986 Oct 08; 99(811):757-9. PubMed ID: 2877428
    [No Abstract] [Full Text] [Related]

  • 68. Pregnancy and inflammatory bowel disease.
    Korelitz BI.
    Compr Ther; 1982 Jun 08; 8(6):67-70. PubMed ID: 6125298
    [No Abstract] [Full Text] [Related]

  • 69. [Surface necroses of the skin following sulfasalazine therapy in ulcerative colitis].
    Krakamp B, Beinhoff U, Knöpfle G, Leidig P.
    Med Klin (Munich); 1988 Sep 16; 83(18):611-2. PubMed ID: 2903432
    [No Abstract] [Full Text] [Related]

  • 70. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
    Allgayer H, Kruis W.
    Dtsch Med Wochenschr; 1985 Nov 22; 110(47):1827-9. PubMed ID: 2866083
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec 22; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Inflammatory bowel disease. Part II.
    Hansen R.
    Proc Annu Meet Med Sect Am Counc Life Insur; 1978 Dec 22; ():41-9. PubMed ID: 39296
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. [Prevention of recurrence of chronic inflammatory bowel diseases].
    Dölle W, Hartmann F.
    Verh Dtsch Ges Inn Med; 1989 Dec 22; 95():322-6. PubMed ID: 2574922
    [No Abstract] [Full Text] [Related]

  • 77. Fibrosing alveolitis and treatment with sulphasalazine.
    Davies D, MacFarlane A.
    Gut; 1974 Mar 22; 15(3):185-8. PubMed ID: 4152289
    [Abstract] [Full Text] [Related]

  • 78. The effect of the acetylator phenotype on the metabolism of sulphasalazine in man.
    Azad Khan AK, Nurazzaman M, Truelove SC.
    J Med Genet; 1983 Feb 22; 20(1):30-6. PubMed ID: 6133000
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R, Walker JG, West B, Hill MJ.
    Gut; 1974 Apr 22; 15(4):344. PubMed ID: 4151868
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.